News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
552,742 Results
Type
Article (16630)
Company Profile (192)
Press Release (537362)
Multimedia
Podcasts (31)
Webinars (15)
Section
Business (185215)
Career Advice (949)
Deals (28184)
Drug Delivery (43)
Drug Development (60777)
Employer Resources (52)
FDA (10992)
Job Trends (10215)
News (266592)
Policy (20628)
Tag
2027 BioCapital Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (1014)
Accelerated approval (34)
ADA (31)
Adcomms (13)
Allergies (119)
Alliances (38642)
ALS (159)
Alzheimer's disease (1234)
Antibody-drug conjugate (ADC) (379)
Approvals (11535)
Artificial intelligence (494)
ASCO (212)
Autoimmune disease (273)
Automation (43)
Bankruptcy (283)
Best Places to Work (8167)
BIO (62)
Biologics (2)
BIOSECURE Act (14)
Biosimilars (144)
BioSpace Insights (53)
Biotechnology (134)
Bladder cancer (163)
Brain cancer (47)
Breast cancer (640)
Cancer (4705)
Cardiovascular disease (301)
Career advice (870)
Career pathing (21)
CAR-T (266)
CDC (15)
Celiac Disease (1)
Cell therapy (734)
Cervical cancer (43)
Clinical research (54816)
Collaboration (1716)
Commercialization (5)
Company closure (1)
Compensation (1515)
Complete response letters (57)
COVID-19 (1233)
CRISPR (83)
C-suite (1063)
Cystic fibrosis (117)
Data (6886)
Denatured (10)
Depression (123)
Dermatology (72)
Diabetes (438)
Diagnostics (4845)
Digital health (42)
Diversity (3)
Diversity, equity & inclusion (17)
Drug discovery (270)
Drug pricing (51)
Drug shortages (8)
Duchenne muscular dystrophy (207)
Earnings (77955)
Editorial (39)
Employer branding (6)
Employer resources (66)
Events (98644)
Executive appointments (928)
FDA (14095)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (21)
Frontotemporal dementia (29)
Funding (1350)
Gene editing (181)
Generative AI (38)
Gene therapy (525)
GLP-1 (501)
Government (1543)
Grass and pollen (2)
Guidances (305)
Healthcare (10806)
Hematology (119)
HIV (63)
Huntington's disease (39)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (86)
Immunology and inflammation (183)
Immuno-oncology (87)
Indications (177)
Infectious disease (1472)
Inflammatory bowel disease (168)
Inflation Reduction Act (6)
Influenza (109)
Intellectual property (292)
Interviews (181)
IPO (13546)
IRA (13)
Job creations (2488)
Job search strategy (730)
JPM (22)
Kidney cancer (18)
Labor market (44)
Layoffs (178)
Leadership (28)
Legal (5733)
Licensing (10)
Liver cancer (63)
Longevity (28)
Lung cancer (640)
Lymphoma (356)
Machine learning (39)
Management (24)
Manufacturing (789)
Marketing (11)
MASH (157)
Medical device (9224)
Medtech (9380)
Mergers & acquisitions (15976)
Metabolic disorders (1022)
mRNA (128)
Multiple sclerosis (150)
NASH (7)
Neurodegenerative disease (327)
Neuropsychiatric disorders (57)
Neuroscience (2390)
Neurotech (1)
NextGen: Class of 2026 (3863)
Non-profit (1379)
Now hiring (8)
Obesity (390)
Opinion (160)
Ovarian cancer (188)
Pain (204)
Pancreatic cancer (262)
Parkinson's disease (278)
Partnered (24)
Patents (548)
Patient recruitment (636)
Peanut (40)
People (47699)
Pharmaceutical (35)
Pharmacy benefit managers (12)
Phase 1 (17958)
Phase 2 (24589)
Phase 3 (16506)
Pipeline (8589)
Policy (129)
Postmarket research (1707)
Preclinical (7688)
Press Release (65)
Prostate cancer (223)
Psychedelics (19)
Radiopharmaceuticals (229)
Rare diseases (840)
Real estate (3980)
Recruiting (33)
Regulatory (17433)
Reports (31)
Research institute (1060)
Resumes & cover letters (127)
Rett syndrome (45)
RNA editing (14)
RSV (56)
Schizophrenia (120)
Series A (245)
Series B (178)
Service/supplier (6)
Sickle cell disease (95)
Special edition (9)
Spinal muscular atrophy (116)
Sponsored (27)
Startups (2602)
State (1)
Stomach cancer (11)
Supply chain (75)
Tariffs (20)
The Weekly (24)
Vaccines (516)
Venture capital (71)
Weight loss (188)
Women's health (100)
Worklife (10)
Date
Today (12)
Last 7 days (251)
Last 30 days (1816)
Last 365 days (22987)
2026 (14960)
2025 (23101)
2024 (26693)
2023 (30625)
2022 (39469)
2021 (42038)
2020 (38010)
2019 (27578)
2018 (21060)
2017 (22267)
2016 (21417)
2015 (27667)
2014 (24179)
2013 (20531)
2012 (22657)
2011 (23099)
2010 (22428)
Location
Africa (438)
Alabama (80)
Alaska (2)
Arizona (324)
Arkansas (12)
Asia (24492)
Australia (3933)
California (13062)
Canada (3452)
China (929)
Colorado (514)
Connecticut (478)
Delaware (252)
Europe (44285)
Florida (1918)
Georgia (400)
Hawaii (4)
Idaho (51)
Illinois (804)
India (78)
Indiana (508)
Iowa (20)
Japan (445)
Kansas (114)
Kentucky (38)
Louisiana (31)
Maine (31)
Maryland (1363)
Massachusetts (9046)
Michigan (318)
Minnesota (594)
Mississippi (5)
Missouri (94)
Montana (29)
Nebraska (12)
Nevada (138)
New Hampshire (68)
New Jersey (2925)
New Mexico (19)
New York (3193)
North Carolina (1449)
North Dakota (10)
Northern California (6645)
Ohio (317)
Oklahoma (15)
Oregon (23)
Pennsylvania (2495)
Puerto Rico (23)
Rhode Island (34)
South America (644)
South Carolina (78)
South Dakota (1)
Southern California (5311)
Tennessee (132)
Texas (2070)
United States (43339)
Utah (391)
Vermont (2)
Virginia (181)
Washington D.C. (45)
Washington State (1055)
West Virginia (3)
Wisconsin (91)
Wyoming (2)
552,742 Results for "turn biotechnologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Turn Therapeutics Provides Corporate Updates and Reports Second Quarter 2026 Financial Results
August 13, 2026
·
9 min read
Press Releases
Scientists Turn COVID-19 Immune Memory into a Powerful New Ally Against Cancer
Nature Communications Publishes Breakthrough Study Showing How COVID-Era Immune Memory Can Be Redirected to Fight Cancer Celloram, Inc., University Hospitals, and Case Western Reserve University unveil PROTEXI, a novel cancer vaccine platform advancing toward first-in-human clinical trials in sarcoma patients.
July 27, 2026
·
1 min read
Press Releases
Conexeu Sciences Sees a New Category Forming in Medical Aesthetics as Research Turns to Regeneration
August 18, 2026
·
10 min read
Opinion
2026 Could Mark a Turning Point for American Innovation
The current state of political affairs in the U.S. does not bode well for the direction of that turn. The country is at real risk of losing its long-held lead in biotech innovation.
February 16, 2026
·
4 min read
·
John Stanford
Press Releases
Turn Therapeutics Announces New Peer-Reviewed Research Showing GX-03 Selectively Reduces Key Drivers of Skin Inflammation and Itch
August 20, 2026
·
6 min read
Press Releases
As mental health patients turn to AI chatbots, how can pharma lead the way?
A new report by Bryter released today reveals where pharma can lead as patients turn to (and question) AI tools for mental health.
February 5, 2026
·
1 min read
Drug Development
India’s life sciences sector at turning point for innovation: Report
Structural gaps in areas including clinical execution and funding limit India’s ability to scale up innovation, according to a report from Boston Consulting Group and HealthKois.
July 17, 2026
·
2 min read
·
Angela Gabriel
Press Releases
Turn Therapeutics to Present at Jefferies Global Healthcare Conference 2026
May 19, 2026
·
1 min read
Press Releases
Turn Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Updates
May 12, 2026
·
5 min read
Manufacturing
Amid $55B US manufacturing push, J&J turns to streamlining its pharma supply chain
After committing $55 billion last year to bolster U.S. manufacturing capabilities, Johnson & Johnson is making changes to its pharmaceutical supply chain.
July 15, 2026
·
1 min read
·
Gabrielle Masson
1 of 55,275
Next
